Literature DB >> 25919150

A learning experience from price negotiations for vaccines.

Yot Teerawattananon1, Nattha Tritasavit2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25919150     DOI： 10.1016/j.vaccine.2014.12.050

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  6 in total

Review 1.  Essential medicines for universal health coverage.

Authors:  Veronika J Wirtz; Hans V Hogerzeil; Andrew L Gray; Maryam Bigdeli; Cornelis P de Joncheere; Margaret A Ewen; Martha Gyansa-Lutterodt; Sun Jing; Vera L Luiza; Regina M Mbindyo; Helene Möller; Corrina Moucheraud; Bernard Pécoul; Lembit Rägo; Arash Rashidian; Dennis Ross-Degnan; Peter N Stephens; Yot Teerawattananon; Ellen F M 't Hoen; Anita K Wagner; Prashant Yadav; Michael R Reich
Journal:  Lancet       Date:  2016-11-08       Impact factor: 79.321

2.  How to Get Cost-Effectiveness Analysis Right? The Case of Vaccine Economics in Latin America.

Authors:  Amanda Glassman; Oscar Cañón; Rachel Silverman
Journal:  Value Health       Date:  2016-12       Impact factor: 5.725

3.  Economic evaluation of rotavirus vaccination in children of Bhutan.

Authors:  Alia Cynthia G Luz; Nantasit Luangasanatip; Pritaporn Kingkaew; Deepika Adhikari; Wanrudee Isaranuwatchai; Dechen Choiphel; Clint Pecenka; Frédéric Debellut
Journal:  Vaccine       Date:  2020-06-07       Impact factor: 3.641

4.  Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region.

Authors:  Quinn Grundy; Lisa Parker; Anna Wong; Terence Fusire; Deirdre Dimancesco; Klara Tisocki; Helena Walkowiak; Taryn Vian; Jillian Kohler
Journal:  Global Health       Date:  2022-03-18       Impact factor: 4.185

Review 5.  A review of promoting access to medicines in China - problems and recommendations.

Authors:  Jing Sun; Cecile Jia Hu; Mark Stuntz; Hans Hogerzeil; Yuanli Liu
Journal:  BMC Health Serv Res       Date:  2018-02-20       Impact factor: 2.655

6.  Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.

Authors:  Chris Painter; Wanrudee Isaranuwatchai; Juthamas Prawjaeng; Hwee Lin Wee; Brandon Wen Bing Chua; Vinh Anh Huynh; Jing Lou; Fang Ting Goh; Nantasit Luangasanatip; Wirichada Pan-Ngum; Wang Yi; Hannah Clapham; Yot Teerawattananon
Journal:  Appl Health Econ Health Policy       Date:  2021-07-08       Impact factor: 2.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.